Search
for
Sort by
Research 61–90 of 1000+
- INTERFERONS IN DERMATOLOGY
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Hypertrichosis of the pinnae in a patient using panitumumab
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Psychological burden of alopecia areata in patients with cancer: A narrative review
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Contents
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Contents
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Multiple minute digitate hyperkeratosis
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- TOC
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Phenol in dermatology: updated evidence on efficacy and safety
- Chemotherapy and Cutaneous Drug Reactions
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes